X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1377) 1377
Publication (206) 206
Patent (24) 24
Book Chapter (14) 14
Conference Proceeding (11) 11
Book Review (10) 10
Book / eBook (6) 6
Web Resource (4) 4
Magazine Article (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (867) 867
female (773) 773
oncology (690) 690
middle aged (503) 503
breast cancer (492) 492
breast neoplasms - drug therapy (463) 463
breast neoplasms - pathology (435) 435
adult (434) 434
aged (416) 416
index medicus (383) 383
antineoplastic combined chemotherapy protocols - therapeutic use (226) 226
prognosis (222) 222
chemotherapy (219) 219
cancer (190) 190
treatment outcome (166) 166
breast neoplasms - mortality (164) 164
survival (158) 158
neoplasm staging (154) 154
disease-free survival (148) 148
breast neoplasms - genetics (141) 141
therapy (140) 140
article (137) 137
aged, 80 and over (133) 133
care and treatment (130) 130
research (130) 130
retrospective studies (126) 126
breast neoplasms - metabolism (123) 123
breast neoplasms - therapy (123) 123
neoplasm metastasis (118) 118
chemotherapy, adjuvant (117) 117
carcinoma (110) 110
breast neoplasms - surgery (107) 107
metastasis (107) 107
antineoplastic agents - therapeutic use (98) 98
medicine & public health (94) 94
trastuzumab (93) 93
doxorubicin - administration & dosage (92) 92
risk factors (91) 91
combined modality therapy (90) 90
women (90) 90
neoadjuvant therapy (87) 87
cyclophosphamide - administration & dosage (83) 83
survival analysis (81) 81
doxorubicin (79) 79
adjuvant chemotherapy (78) 78
fluorouracil - administration & dosage (78) 78
survival rate (78) 78
male (75) 75
time factors (75) 75
follow-up studies (71) 71
lymphatic metastasis (70) 70
surgery (70) 70
animals (69) 69
health aspects (69) 69
antineoplastic combined chemotherapy protocols - adverse effects (67) 67
paclitaxel (66) 66
expression (65) 65
preoperative chemotherapy (64) 64
patient outcomes (63) 63
proportional hazards models (62) 62
receptor, erbb-2 - metabolism (62) 62
drug administration schedule (61) 61
tumors (59) 59
cyclophosphamide (58) 58
neoadjuvant chemotherapy (58) 58
abridged index medicus (57) 57
drug therapy (57) 57
risk (57) 57
tamoxifen (57) 57
diagnosis (56) 56
trial (55) 55
analysis (54) 54
antineoplastic agents - administration & dosage (54) 54
cancer patients (54) 54
kaplan-meier estimate (54) 54
recurrence (54) 54
genetic aspects (53) 53
mastectomy (53) 53
prospective studies (52) 52
radiotherapy (52) 52
mice (51) 51
breast-cancer (50) 50
postmenopausal women (49) 49
bone neoplasms - secondary (48) 48
clinical trials as topic (47) 47
paclitaxel - administration & dosage (47) 47
cell line, tumor (46) 46
multivariate analysis (46) 46
receptors, estrogen - analysis (45) 45
receptors, estrogen - metabolism (45) 45
metastatic breast cancer (44) 44
mutation (44) 44
predictive value of tests (44) 44
breast neoplasms - diagnosis (43) 43
gene expression (43) 43
docetaxel (42) 42
skin and connective tissue diseases (42) 42
surgical adjuvant breast (42) 42
antibodies, monoclonal, humanized (41) 41
clinical trials (41) 41
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Circulation Desk (1) 1
Scarborough Hospital - General (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BREAST CANCER RESEARCH, ISSN 1465-542X, 10/2018, Volume 20, Issue 1, pp. 123 - 11
Endocrine therapy is recommended for patients with hormone receptor-positive (HR+) advanced and metastatic breast cancer without visceral crisis (symptomatic... 
PALOMA-1/TRIO-18 | METASTASIS | Ribociclib | Endocrine therapy | 6 inhibitor | COMBINATION | MONALEESA-2 | PALBOCICLIB | WOMEN | THERAPY | ONCOLOGY | CDK4 | LETROZOLE | BONE | Hormone receptor-positive | HR+/HER2(-) breast cancer | Hormone receptors | Care and treatment | Cancer patients | Breast cancer | Drug therapy | Health aspects | Statistics | HER2− breast cancer | HR | Review | HR+/HER2− breast cancer | CDK4/6 inhibitor
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 02/2006, Volume 354, Issue 6, p. 643
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 20, pp. 3366 - 3379
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 11/2012, Volume 136, Issue 2, pp. 331 - 345
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 55 - 65
Journal Article
Journal Article